Tag: Andree Amelsberg
FDA approves IMBRUVICA, rituximab combo for rare blood cancer
Janssen Pharmaceutical has bagged approval from the US Food and Drug Administration (FDA) for its combo of IMBRUVICA (ibrutinib) and rituximab for the treatment of ... Read More